Table 2 Patient and treatment characteristics

Sex (n)

 Male

8

 Female

7

Age at diagnosis (years)

 Median

8

 Range

4–16

Staging (n)

 SR

7

 HR M0

0

 HR M1

4

 HR M2

1

 HR M3

3

Time between surgery and start RT (days)

 Median

31

 Range

15–43

 95 % CI median

29–32

CSI dose (n)

 23.4 Gy/1.8

7

 36.0 Gy/1.8

8

Patients receiving cranial/spinal boost (n)

4

 Cranial boost

3

 Spinal boost

3

Overall treatment time RT (days)

 Median

42

 Range

39–43

 95 % CI median

41–42

Patients with treatment interruptions (n)

1

 Treatment interruptions (days)

1

Chemotherapy (n)

 SR (Concomitant and Adjuvant)

7

 HR (Concomitant and Adjuvant)

2

 HR (Adjuvant only)

6